244 related articles for article (PubMed ID: 23669187)
21. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
Vuorio T; Kähäri VM; Black C; Vuorio E
J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
[TBL] [Abstract][Full Text] [Related]
22. [Eosinophilic fasciitis (Shulman syndrome)--a contribution to the differential diagnosis of sclerodermiform diseases].
Rietzschel I; Wozel G; Hackert I
Z Arztl Fortbild (Jena); 1988; 82(6):281-4. PubMed ID: 3407220
[No Abstract] [Full Text] [Related]
23. Morphoea-like plaques revealing an eosinophilic (Shulman) fasciitis.
Moulin C; Cavailhes A; Balme B; Skowron F
Clin Exp Dermatol; 2009 Dec; 34(8):e851-3. PubMed ID: 19843081
[TBL] [Abstract][Full Text] [Related]
24. The roles of transforming growth factor type beta3 (TGF-beta3) and mast cells in the pathogenesis of scleroderma.
Ozbilgin MK; Inan S
Clin Rheumatol; 2003 Sep; 22(3):189-95. PubMed ID: 14505209
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.
Bischoff L; Derk CT
Int J Dermatol; 2008 Jan; 47(1):29-35. PubMed ID: 18173597
[TBL] [Abstract][Full Text] [Related]
26. [Eosinophilic fasciitis: report of 3 cases].
Velásquez X; Gutiérrez MA; Rosenberg H; Figueroa F; Bronstein E; Jacobelli S
Rev Med Chil; 2002 Feb; 130(2):209-14. PubMed ID: 11974534
[TBL] [Abstract][Full Text] [Related]
27. Scleroderma, eosinophilia, and diffuse fasciitis.
Fleischmajer R; Jacotot AB; Shore S; Binnick SA
Arch Dermatol; 1978 Sep; 114(9):1320-5. PubMed ID: 686745
[TBL] [Abstract][Full Text] [Related]
28. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
29. Reversible scleroderma, fasciitis and perimyositis.
Bondeson J; Rausing A
Clin Exp Rheumatol; 1994; 12(1):71-3. PubMed ID: 8162647
[TBL] [Abstract][Full Text] [Related]
30. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
[TBL] [Abstract][Full Text] [Related]
31. Light-chain-restricted plasmacellular infiltrates in necrobiosis lipoidica -- a clue to an underlying monoclonal gammopathy.
Cioc AM; Frambach GE; Magro CM
J Cutan Pathol; 2005 Apr; 32(4):263-7. PubMed ID: 15769274
[TBL] [Abstract][Full Text] [Related]
32. Eosinophilic fasciitis/generalized morphea overlap.
Heidary N; Cheung W; Wang N; Kamino H; Franks AG
Dermatol Online J; 2009 Aug; 15(8):2. PubMed ID: 19891910
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic fasciitis. Immunopathology, ultrastructure, literature review, and consideration of its pathogenesis and relation to scleroderma.
Cramer SF; Kent L; Abramowsky C; Moskowitz RW
Arch Pathol Lab Med; 1982 Feb; 106(2):85-91. PubMed ID: 7036939
[No Abstract] [Full Text] [Related]
34. L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis.
Freundlich B; Werth VP; Rook AH; O'Connor CR; Schumacher HR; Leyden JJ; Stolley PD
Ann Intern Med; 1990 May; 112(10):758-62. PubMed ID: 2331120
[TBL] [Abstract][Full Text] [Related]
35. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
36. Eosinophilic fascitis (Shulman syndrome) in a 13-year-old girl.
Clemmensen OJ; Thomsen K
Acta Derm Venereol; 1980; 60(3):271-4. PubMed ID: 6158236
[TBL] [Abstract][Full Text] [Related]
37. Presence of eosinophilia in progressive systemic sclerosis and localized scleroderma.
Giordano M; Ara M; Valentini G; Chianese U; Bencivenga T
Arch Dermatol Res; 1981; 271(4):411-7. PubMed ID: 7332350
[TBL] [Abstract][Full Text] [Related]
38. Eosinophilic fasciitis--progression to linear scleroderma: a case report.
Balat A; Akinci A; Turgut M; Mizrak B; Aydin A
Turk J Pediatr; 1999; 41(3):381-5. PubMed ID: 10770102
[TBL] [Abstract][Full Text] [Related]
39. [Eosinophilic fasciitis and related diseases].
Sáez Barcelona JA
An Med Interna; 1999 Sep; 16(9):477-83. PubMed ID: 10609364
[TBL] [Abstract][Full Text] [Related]
40. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions.
Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A
Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
